Follow us for updates
© 2022 reportr.world
Read the Story →

1.15 Million More Doses of AstraZeneca Vaccine Arrive in Philippines

More vaccines.
by Arianne Merez
Jul 16, 2021
Photo/s: Shutterstock
Shares

Another 1.15 million doses of the AstraZeneca COVID-19 vaccine arrived in Manila on Friday, boosting the country's supply of jabs.

The vaccines are part of the procured jabs by the private sector through a tripartite deal involving the national government.

“We need a fast and almost perfect rollout and the private sector, with the arrival of these initial doses from AstraZeneca, can now do that for its employees,”  Presidential Adviser for Entrepreneurship Joey Concepcion said in a statement.

Last month, Concepcion said he was informed by COVID-19 vaccine czar Sec. Carlito Galvez Jr. that the private sector no longer needs to donate some of the AstraZeneca jabs they procured to the government.

Concepcion had said that businessmen want inoculation to be focused in major urban hubs--Metro Manila, Pampanga, Bulacan, Laguna, Cavite, Rizal, Cebu, and Davao--to revive the economy.

Some 50 million Filipinos should be vaccinated against COVID-19 by November this year for the government to achieve its target of "population protection."

Continue reading below ↓

MORE FROM REPORTR.WORLD

Reportr is now on Quento. Download the app on iOS and Android or visit the Quento website for more articles and videos from Reportr and your favorite websites.

Continue reading below ↓
Recommended Videos
Latest Headlines
Read Next
Recent News
With the reopening of several local destinations, this app has never been more timely.
The focus should be on the poor, incoming senator said.
GCash isn't just about paying bills and transferring funds.
You'll need a bigger wallet, incoming BSP gov says.
The news. So what? Subscribe to the newsletter that explains what the news means for you.
The email address you entered is invalid.
Thank you for signing up to On Three, reportr's weekly newsletter delivered to your mailbox three times a week. Only the latest, most useful and most insightful reads.
By signing up to reportr.world newsletter, you agree to our Terms of Service and Privacy Policy.